Navigation Links
Sequenom Announces Publication Acceptance of Manuscript From Age-related Macular Degeneration Validation Study
Date:4/28/2011

ment regulation particularly with respect to diagnostic products and laboratory developed tests, obtaining or maintaining regulatory approvals, ongoing litigation and investigations and other risks detailed from time to time in Sequenom, Inc.'s most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and Sequenom, Inc. undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
2. Sequenom Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
3. Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
4. Sequenom to Present at Two Financial Conferences in September
5. Sequenom to Present at Two Financial Conferences in March
6. Sequenom Appoints Two New Board Members
7. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
8. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
9. SEQUENOM Announces Launch of MassARRAY Compact 96 System
10. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
11. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Proove ... new data on the relationship of genetics and hypertension at the International ... Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview ...
(Date:8/26/2015)... 2015  The Diabetes Research Institute (DRI), a ... Miller School of Medicine, announced today that the ... for the first time a novel transplant technique ... approved Phase I/II study builds upon decades of ... important first step toward the development of the ...
(Date:8/26/2015)... , August 26, 2015 After litigating ... Europlasma NV relating to P2i United States ... their dispute in the United States ... the part of either party. As a result of the ... of California dismissed the case without ...
(Date:8/25/2015)... ... August 25, 2015 , ... ... tissue lesions are cancerous is described by University of Illinois researchers in the ... optics and photonics. , In “ Breast cancer diagnosis using spatial light interference ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... Effective Localized Pain Management, NESHER, Israel, October ... the US Food and Drug Administration (FDA),has granted ... device,used to treat pain. PainShield is the first ... new dimension in ultrasound,treatment of pain and soft ...
... Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... Shizuko Sei of SAIC-Frederick,Inc., delivered a poster ... of Intravenously Administered Oncolytic Reovirus in,Nude Mice ... EORTC-NCI-AACR,Symposium on Molecular Targets and Cancer Therapeutics. ...
... Corporation (Nasdaq: UTHR ) announced today that ... before market open on,Thursday, October 30, 2008., ... Thursday,October 30, 2008, at 9:00 a.m. Eastern Time. ... callers dialing,1-706-679-8129. A rebroadcast of the teleconference will ...
Cached Biology Technology:NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device 2Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium 2Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium 3
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 /PRNewswire/ ... and services for gene function analysis and biomarker ... Guide RNA (sgRNA) Knockout Library targeting all human ... specifically and permanently "knock out" a gene,s function. ... provides a high throughput screening tool so that ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... , Apoptosis, programmed cell death, is essential to ... prevention. The process dramatically transforms cellular structures but ... much about this structural reorganization a mystery. , ... the current issue of Proceedings of the ...
... 2010 [Vienna, Austria] The appalling lack of access to ... including sex workers, men who have sex with men ... scale up of simple and inexpensive treatment regimens to ... rights violations that threaten future progress on AIDS, according ...
... is associated with significantly elevated rates of heart disease in ... published in this month,s issue of the journal Child ... had been physically abused as children had 45 per cent ... not been abused, despite the fact we had adjusted for ...
Cached Biology News:How do cells die? Biophotonic tools reveal real-time dynamics in living color 2How do cells die? Biophotonic tools reveal real-time dynamics in living color 3Lack of access to evidence-based HIV prevention and care is a fundamental violation of human rights 2Lack of access to evidence-based HIV prevention and care is a fundamental violation of human rights 3Lack of access to evidence-based HIV prevention and care is a fundamental violation of human rights 4U of T researchers find link between childhood physical abuse and heart disease 2
MagSi monodispers, magnetic silica particles with modified surface for SO3 coupling chemistry....
Recognizes a full-length CLC-2 voltage-gated Cl- protein and not with other known proteins tested so far....
Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: